To create a decision analytic model to estimate the balance between treatment risks and benefits for severely obese patients with diabetes.
Bariatric surgery leads to many desirable metabolic changes, but long-term impact of bariatric surgery on life expectancy in patients with diabetes has not yet been quantified.
We developed a Markov state transition model with multiple Cox proportional hazards models and logistic regression models as inputs to compare bariatric surgery versus no surgical treatment for severely obese diabetic patients. The model is informed by data from 3 large cohorts: (1) 159,000 severely obese diabetic patients (4185 had bariatric surgery) from 3 HMO Research Network sites; (2) 23,000 subjects from the Nationwide Inpatient Sample; and (3) 18,000 subjects from the National Health Interview Survey linked to the National Death Index.
In our main analyses, we found that a 45-year-old woman with diabetes and a body mass index (BMI) of 45 kg/m2 gained an additional 6.7 years of life expectancy with bariatric surgery (38.4 years with surgery vs 31.7 years without surgery). Sensitivity analyses revealed that the gain in life expectancy decreased with increasing BMI, until a BMI of 62 kg/m2 is reached, at which point nonsurgical treatment was associated with greater life expectancy. Similar results were seen for both men and women in all age groups.
For most severely obese patients with diabetes, bariatric surgery seems to improve life expectancy; however, surgery may reduce life expectancy for the super obese with BMIs over 62 kg/m2.
A decision analysis was performed to estimate the change in life expectancy associated with bariatric surgery for severely obese patients with diabetes. Most patients with a body mass index of less than 62 m/kg2 benefited from surgery, whereas those with a body mass index above this threshold did not.
*Division of General Internal Medicine and Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH
†Group Health Center for Health Studies, Seattle, WA
‡Department of Gastrointestinal and Endocrine Surgery, University of Texas Southwestern, School of Medicine, Dallas, TX
§Kaiser Permanente Southern California, Pasadena, CA
¶Kaiser Permanente Northern California, Oakland, CA
‖Health Partners Institute for Education and Research, Minneapolis, MN
**Division of General Surgery, University of Cincinnati Medical Center, Cincinnati, OH.
Reprints: Daniel P. Schauer, MD, MSc, Division of General Internal Medicine, University of Cincinnati, PO Box 670535, Cincinnati, OH 45267. E-mail: Daniel.Schauer@uc.edu.
Disclosure: Supported by NIH/NIDDK 1K23DK075599-01A1. The authors declare no conflicts of interest.